Zhongmin Jiang

924 total citations
40 papers, 611 citations indexed

About

Zhongmin Jiang is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Zhongmin Jiang has authored 40 papers receiving a total of 611 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 15 papers in Cancer Research and 10 papers in Oncology. Recurrent topics in Zhongmin Jiang's work include Ubiquitin and proteasome pathways (8 papers), MicroRNA in disease regulation (7 papers) and Cancer, Hypoxia, and Metabolism (6 papers). Zhongmin Jiang is often cited by papers focused on Ubiquitin and proteasome pathways (8 papers), MicroRNA in disease regulation (7 papers) and Cancer, Hypoxia, and Metabolism (6 papers). Zhongmin Jiang collaborates with scholars based in China, United States and Philippines. Zhongmin Jiang's co-authors include Xiaozhi Liu, Zhenlin Liu, Shizhu Yu, Yanxia Li, Xiaozhi Liu, Jianyong Huang, Simiao Yu, Shuqiang Huang, Xiaofang Ma and Wenhan Wu and has published in prestigious journals such as Scientific Reports, Journal of Chromatography A and Molecules.

In The Last Decade

Zhongmin Jiang

38 papers receiving 608 citations

Peers

Zhongmin Jiang
Qi Wan China
Xianli He China
Zhi‐Jun Pei China
Xiao Sun China
Changwen Jing China
Aswin Abraham Canada
Qi Wan China
Zhongmin Jiang
Citations per year, relative to Zhongmin Jiang Zhongmin Jiang (= 1×) peers Qi Wan

Countries citing papers authored by Zhongmin Jiang

Since Specialization
Citations

This map shows the geographic impact of Zhongmin Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhongmin Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhongmin Jiang more than expected).

Fields of papers citing papers by Zhongmin Jiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhongmin Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhongmin Jiang. The network helps show where Zhongmin Jiang may publish in the future.

Co-authorship network of co-authors of Zhongmin Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Zhongmin Jiang. A scholar is included among the top collaborators of Zhongmin Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhongmin Jiang. Zhongmin Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
He, Lijie, Zhongmin Jiang, Jing Wang, & Zhe Han. (2025). Mechanism of miR-200b-3p-induced FOSL2 inhibition of endometrial cancer cell proliferation and metastasis. Scientific Reports. 15(1). 15742–15742.
2.
Jiang, Zhongmin, Yang Yu, Li Li, et al.. (2024). A chiral porous organic cage–modified restricted-access material achieves online analysis of serum samples containing enantiomers and positional isomers. Journal of Chromatography A. 1740. 465561–465561. 2 indexed citations
3.
Zheng, Jie, Jin Liu, Yanxia Li, et al.. (2024). Pan-cancer analyses reveal the molecular and clinical characteristics of TET family members and suggests that TET3 maybe a potential therapeutic target. Frontiers in Pharmacology. 15. 1418456–1418456. 5 indexed citations
4.
Jiang, Zhongmin, et al.. (2023). Establishment and validation of an immune infiltration predictive model for ovarian cancer. BMC Medical Genomics. 16(1). 227–227. 1 indexed citations
5.
Jiang, Zhongmin, et al.. (2023). Detection of CSTF2 by nano fluorescent probe and its correlation with malignant biological characteristics in liver cancer. PubMed Central.
6.
Zheng, Yushan, Zhiguo Jiang, Jun Shi, et al.. (2021). Encoding histopathology whole slide images with location-aware graphs for diagnostically relevant regions retrieval. Medical Image Analysis. 76. 102308–102308. 16 indexed citations
7.
Sun, Yajing, Min Liu, Zhongmin Jiang, & Baojiang Li. (2020). Bronchiolar adenoma with diffuse pulmonary nodules: a extremely rare case report and review of literature. BMC Pulmonary Medicine. 20(1). 192–192. 8 indexed citations
8.
Zhang, Chunyan, Zhongmin Jiang, Xiaofang Ma, et al.. (2019). Saikosaponin-d Inhibits the Hepatoma Cells and Enhances Chemosensitivity Through SENP5-Dependent Inhibition of Gli1 SUMOylation Under Hypoxia. Frontiers in Pharmacology. 10. 1039–1039. 43 indexed citations
9.
Wang, Jiansong, et al.. (2019). <p>CDKN3 promotes tumor progression and confers cisplatin resistance via RAD51 in esophageal cancer</p>. Cancer Management and Research. Volume 11. 3253–3264. 28 indexed citations
10.
Liu, Feiyu, et al.. (2017). Glutathione S-transferase A1 mediates nicotine-induced lung cancer cell metastasis by promoting epithelial-mesenchymal transition. Experimental and Therapeutic Medicine. 14(2). 1783–1788. 22 indexed citations
11.
12.
Ma, Xiaofang, Xiaozhi Liu, Yanxia Li, et al.. (2017). Moderate hypothermia induces protein SUMOylation in bone marrow stromal cells and enhances their tolerance to hypoxia. Molecular Medicine Reports. 16(5). 7006–7012. 3 indexed citations
13.
Liu, Peng, et al.. (2016). A giant infiltrating angiolipoma of the mediastinum: a case report. Journal of Cardiothoracic Surgery. 11(1). 164–164. 7 indexed citations
14.
Zhang, Xianqi, Chunhong Wang, Shan Shan, et al.. (2016). TLR4/ROS/miRNA-21 pathway underlies lipopolysaccharide instructed primary tumor outgrowth in lung cancer patients. Oncotarget. 7(27). 42172–42182. 43 indexed citations
15.
16.
Zhu, Qiang, Zhongmin Jiang, Wei Wang, et al.. (2015). Clinical Application of Recombinant Human Endostatin in Postoperative Early Complementary Therapy on Patients with Non-small Cell Lung Cancer in Chinese Mainland. Asian Pacific Journal of Cancer Prevention. 16(9). 4013–4018. 8 indexed citations
17.
Xing, Ligang, Jiandong Zhang, Peipei Wu, et al.. (2014). Definitive chemoradiotherapy with capecitabine and cisplatin for elder patients with locally advanced squamous cell esophageal cancer. Journal of Cancer Research and Clinical Oncology. 140(5). 867–872. 18 indexed citations
18.
Liu, Zhenlin, Zhongmin Jiang, Jianyong Huang, et al.. (2014). miR-7 inhibits glioblastoma growth by simultaneously interfering with the PI3K/ATK and Raf/MEK/ERK pathways. International Journal of Oncology. 44(5). 1571–1580. 123 indexed citations
19.
Liu, Zhenlin, Zhongmin Jiang, Jianyong Huang, et al.. (2014). Mesenchymal stem cells show little tropism for the resting and differentiated cancer stem cell-like glioma cells. International Journal of Oncology. 44(4). 1223–1232. 11 indexed citations
20.
Jiang, Zhongmin, Yazhou Cui, Lin Wang, et al.. (2013). Investigating citrullinated proteins in tumour cell lines. World Journal of Surgical Oncology. 11(1). 260–260. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Qi Wan Breakdown of academic impact, for papers by Xianli He Breakdown of academic impact, for papers by Zhi‐Jun Pei Breakdown of academic impact, for papers by Xiao Sun Breakdown of academic impact, for papers by Changwen Jing Breakdown of academic impact, for papers by Aswin Abraham
Rankless by CCL
2026